HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Figures Only Full Text Full Text (PDF) All Versions of this Article: jnumed.108.052746v1 50/1/18    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Related articles in JNM Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Schmidt, D. Articles by Kuwert, T. Search for Related Content PubMed PubMed Citation Articles by Schmidt, D. Articles by Kuwert, T.

Impact of ¹³¹I SPECT/Spiral CT on Nodal Staging of Differentiated Thyroid Carcinoma at the First Radioablation

¹ Clinic of Nuclear Medicine, University of Erlangen-Nürnberg, Erlangen, Germany; and ² Institute of Radiology, University of Erlangen-Nürnberg, Erlangen, Germany

Correspondence: For correspondence or reprints contact: Daniela Schmidt, Clinic of Nuclear Medicine, University of Erlangen-Nürnberg, Krankenhausstrasse 12, D-91054 Erlangen, Germany. E-mail: Daniela.Schmidt{at}uk-erlangen.de

The purpose of this study was to determine the diagnostic value of ¹³¹I SPECT/spiral CT (SPECT/CT) on nodal staging of patients with thyroid carcinoma at the first ablative radioiodine therapy. Methods: Fifty-seven patients were studied using SPECT/CT 3–4 d after receiving 3.96 ± 0.5 GBq of ¹³¹I for radioablation of thyroid remnants after a thyroidectomy for differentiated thyroid carcinoma. In addition to planar whole-body scintigraphy, SPECT/CT of the neck was performed using a hybrid camera combining a double-head SPECT camera with either a 2-slice (n = 23) or a 6-slice (n = 34) spiral CT scanner. The planar scans and the SPECT/CT images were evaluated for cervical tracer uptake independently of each other and of the clinical findings. Results: SPECT/CT led to a revision of the original diagnosis in 28 of 143 cervical foci of radioiodine uptake seen on planar imaging. In particular, SPECT/CT reclassified as benign 6 of 11 lesions considered to be lymph node metastases and 11 of 15 lesions considered to be indeterminate. Furthermore, SPECT/CT allowed the identification of 11 lymph node metastases classified as thyroid remnant or as indeterminate on planar imaging. Based on this revision, SPECT/CT yielded a gain in information on nodal stage in 20 of the 57 patients studied (35%, P < 0.03). SPECT/CT altered nodal stage from N0 to N1 in 2 of 20 patients and from indeterminate (Nx) to N1 in 6 of 30 patients. The result was a change in risk stratification conforming to the classification proposed by the International Union Against Cancer in 14 patients (25%). Conclusion: SPECT/CT determines lymph node involvement at radioablation performed for thyroid cancer more accurately than does planar imaging. SPECT/CT may alter management in roughly one quarter of patients with thyroid carcinoma by upstaging or downstaging their disease.

Key Words: SPECT/CT • hybrid imaging • registration • thyroid carcinoma • radioiodine

COPYRIGHT © 2009 by the Society of Nuclear Medicine, Inc.

Related articles in JNM:

This Month in JNM

JNM 2009 50: 11A-12A. [Full Text]  

This article has been cited by other articles:

				R. Oommen Scintigraphic TNM Staging of Tumors: A Proposition J. Nucl. Med., August 1, 2009; 50(8): 1386 - 1386. [Full Text] [PDF]

				A. Spanu and G. Madeddu Reply: Scintigraphic TNM Staging of Tumors: A Proposition J. Nucl. Med., August 1, 2009; 50(8): 1386 - 1386. [Full Text] [PDF]

				N. Aide, N. Heutte, J.-P. Rame, E. Rousseau, C. Loiseau, M. Henry-Amar, and S. Bardet Clinical Relevance of Single-Photon Emission Computed Tomography/Computed Tomography of the Neck and Thorax in Postablation 131I Scintigraphy for Thyroid Cancer J. Clin. Endocrinol. Metab., June 1, 2009; 94(6): 2075 - 2084. [Abstract] [Full Text] [PDF]